Small Molecules
31 March 2020
Bellerophon Therapeutics Announces First Patient Treated with INOpulse® Inhaled Nitric Oxide Therapy for COVID-1931 March 2020
Chi-Med Initiates a Phase II Trial of HMPL-453 in Patients with Advanced Malignant Mesothelioma in China31 March 2020
Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis30 March 2020
Rivaroxaban significantly reduced risk of major venous thromboembolism following nonmajor orthopaedic surgery30 March 2020
Lundbeck announces phase IIa study results of Lu AG06466 in adults with Tourette Syndrome30 March 2020
Lundbeck reports headline results from phase IIa AMBLED study of foliglurax in Parkinson’s disease27 March 2020
FDA Accepts Genentech’s New Drug Application for Xofluza for the Treatment of Influenza In ChildrenNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports